Home / Clinical Guideline Hubs / Chapter 3.6
Section 3 — Cardiovascular Management Verify against local policy v1.0 · July 2026

Chapter 3.6 — Neonatal Hypotension & Blood Pressure Management

Treating the circulation, not just a number: perfusion-based assessment, the limits of the "MAP = gestational age" rule, and a stepwise approach to volume, inotropes, and hydrocortisone — built on West Midlands Neonatal Guidelines 2025–28 and current hemodynamic evidence

Educational guideline — verify locally. There is no universally agreed blood-pressure threshold for treatment in preterm infants; treat based on perfusion and the whole clinical picture. All vasoactive drug doses must be verified against the Neonatal Formulary and local policy. Does not replace attending judgment.
BEDSIDE ACTION BOX

1. Overview

Overview

Neonatal blood-pressure management is one of the most nuanced areas in the NICU. Blood pressure is only a surrogate for the real goal — adequate tissue perfusion and oxygen delivery. A given number may be normal for one infant and inadequate for another, and treating an isolated low reading with fluids and pressors can cause harm. The modern approach is to assess perfusion, identify the mechanism, and treat the cause with a targeted, stepwise strategy.

Why This Topic Matters

Both under- and over-treatment carry risk: inadequate perfusion contributes to organ injury (including IVH), while inappropriate fluid boluses and pressors are associated with harm. There is no consensus BP threshold in preterm infants, making perfusion-based, mechanism-targeted care essential.

2. Who This Guideline Applies To

Scope
  • Neonates with low blood pressure and/or signs of poor perfusion/shock.
  • Preterm infants in the transitional period and infants with sepsis, blood loss, or cardiac dysfunction.
  • Cross-references: circulatory insufficiency/shock (3.2), PPHN (6.3/3.2), PDA (3.7), sepsis (8.1/8.2), and adrenal insufficiency (4.3).

3. Key Definitions

TermDefinition
HypotensionBlood pressure below a defined threshold — but no single threshold reliably defines inadequate perfusion.
"MAP ≥ gestational age" ruleA rough guide (mean arterial pressure in mmHg ≥ completed weeks) — a starting reference, not a treatment trigger.
ShockInadequate tissue perfusion/oxygen delivery; may occur with normal or low blood pressure.
Vasopressor-resistant hypotensionHypotension persisting despite volume and adequate inotrope/vasopressor doses; consider adrenal insufficiency.

4. Perfusion-Based Assessment

Look Beyond the Number
  • Capillary refill time, skin color/mottling, and core–peripheral temperature gap.
  • Heart rate, urine output, mental status/tone, and metabolic acidosis/lactate trend.
  • Blood pressure (mean and diastolic) in context; use the "MAP ≥ GA" figure only as a rough reference.
  • Functional echocardiography where available to define the mechanism (filling, contractility, PDA, PPHN).

5. Mechanisms of Hypotension

MechanismExamplesTargeted treatment
HypovolemiaAcute blood loss (abruption, feto-maternal, subgaleal), dehydration.Volume replacement (± blood for hemorrhage).
Myocardial dysfunctionAsphyxia, sepsis, PPHN, metabolic.Inotrope (e.g., dobutamine); treat cause.
Vasodilation/distributiveSepsis, vasodilatory shock.Vasopressor; antibiotics; consider steroids if refractory.
ObstructiveTension pneumothorax, tamponade, duct-dependent lesion.Relieve obstruction (decompress; prostaglandin).
Adrenal insufficiencyRelative adrenal insufficiency (preterm/critically ill).Hydrocortisone.

6. Management Algorithm

1
Assess perfusion, not just BP
Capillary refill, lactate, urine output, mentation, heart rate; is there true circulatory compromise?
2
Identify the mechanism
Hypovolemia vs myocardial dysfunction vs vasodilation vs obstruction/adrenal; use echocardiography if available.
3
Treat reversible causes
Decompress pneumothorax; prostaglandin for duct-dependent lesion; antibiotics for sepsis; blood for hemorrhage.
4
Volume if indicated
10 mL/kg 0.9% saline (or blood) for hypovolemia/loss; reassess; avoid routine repeated boluses in stable preterm infants.
5
Inotrope/vasopressor
Match to physiology (dopamine/dobutamine first-line; adrenaline/noradrenaline for refractory shock) per local policy.
6
Refractory → hydrocortisone & reassess
Consider hydrocortisone for vasopressor-resistant hypotension; re-search for a missed cause; involve seniors.

7. Volume Expansion

Use Judiciously
  • Indicated for hypovolemia/acute loss: 10 mL/kg 0.9% saline over ~15–30 min, repeated with reassessment; give blood for significant hemorrhage.
  • Avoid routine or repeated large boluses in normovolemic preterm infants (associated with harm, including IVH/BPD); most preterm hypotension is not hypovolemic.
  • Reassess perfusion after each bolus rather than giving fixed multiple boluses reflexively.

8. Inotropes & Vasopressors

Agent Selection (Verify Doses Locally)

Choose the agent to match the mechanism; titrate to perfusion and blood pressure per local policy.

AgentMain effectTypical role
DopamineInotrope/vasopressor (dose-dependent).Common first-line for hypotension.
DobutamineInotrope (improves contractility/output).Myocardial dysfunction/low output.
Adrenaline (epinephrine)Potent inotrope/vasopressor.Refractory shock.
Noradrenaline (norepinephrine)Vasopressor.Vasodilatory/septic shock.
MilrinoneInodilator.Selected low-output/PPHN states (specialist).
⚠ Verify

All vasoactive infusion doses, dilutions, and titration must follow the Neonatal Formulary and local policy — flagged for expert review.

9. Hydrocortisone for Refractory Hypotension

Vasopressor-Resistant Hypotension
  • Consider hydrocortisone when hypotension persists despite volume and adequate inotrope/vasopressor support (relative adrenal insufficiency is common in sick/preterm infants).
  • It often improves blood pressure and allows weaning of vasopressors; dose per local policy (see 4.3).
  • Continue to search for and treat the underlying cause; monitor glucose and for other steroid effects.

10. Monitoring

ParameterFrequencyAction
Perfusion (cap refill, lactate, urine output)Continuous/serialGuide escalation/de-escalation.
Blood pressure (ideally invasive)Continuous in shockTitrate support; interpret with perfusion.
Echocardiography (functional)As availableDefine mechanism; guide agent choice.
Glucose/electrolytesRegularDetect steroid effects; support metabolism.
Cause-specific (cultures, imaging)As indicatedTreat sepsis/PDA/pneumothorax/hemorrhage.

11. Precautions

Safety Cautions
  • Do not treat an isolated low BP number without assessing perfusion and mechanism.
  • Avoid routine/repeated volume boluses in normovolemic preterm infants (harm, including IVH).
  • Match the vasoactive agent to the physiology; verify all doses.
  • Always search for and treat reversible causes (pneumothorax, duct-dependent lesion, sepsis, hemorrhage).
  • Consider adrenal insufficiency in refractory hypotension; monitor glucose with steroids.

12. Escalation & Family Support

Family-Centered Communication
  • "Your baby's circulation needs support. We look at how well blood is reaching the organs — not just the blood-pressure number — and treat the specific cause."
  • "We may use fluids and medicines that help the heart and blood vessels, and sometimes a steroid if the pressure is hard to support."

13. Key Pearls

High-Value Clinical Pearls
  • Treat perfusion, not an isolated number; there's no consensus BP threshold in preterm infants.
  • "MAP ≥ gestational age" is a rough reference, not a treatment trigger.
  • Identify the mechanism (hypovolemia/myocardial/vasodilation/obstruction/adrenal) and target it.
  • Most preterm hypotension is not hypovolemic — avoid reflexive repeated boluses.
  • Match inotrope/vasopressor to physiology; verify all doses.
  • Hydrocortisone for vasopressor-resistant hypotension; keep hunting for the cause.

14. Common Mistakes to Avoid

MistakeWhy it harmsBetter practice
Treating the number alone.Over/under-treatment.Assess perfusion and mechanism.
Repeated boluses in preterm.IVH/BPD risk.Judicious volume; reassess.
Wrong agent for physiology.Ineffective/harmful.Match agent to mechanism.
Missing obstructive/reversible cause.Ongoing shock.Decompress; prostaglandin; treat sepsis.
Forgetting adrenal insufficiency.Refractory hypotension.Consider hydrocortisone.

15. Board-Style High-Yield Summary

Key Takeaways
  • BP is a surrogate for perfusion; treat the circulation, not an isolated number.
  • No consensus preterm BP threshold; "MAP ≥ GA" is a rough reference only.
  • Identify mechanism (hypovolemia/myocardial/vasodilation/obstruction/adrenal) and target it.
  • Volume (10 mL/kg) for hypovolemia/loss; avoid reflexive repeated boluses in preterm infants.
  • Inotropes/vasopressors matched to physiology (dopamine/dobutamine; adrenaline/noradrenaline in refractory shock).
  • Hydrocortisone for vasopressor-resistant hypotension; always treat the underlying cause.

16. References

Back to Clinical Guideline Hubs